Clinical trials
Uterine Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Seoul National University Hospital | 2 |
| Asan Medical Center | 1 |
| Elevation Oncology | 1 |
| Fore Biotherapeutics | 1 |
| Hallym University Kangnam Sacred Heart Hospital | 1 |
| Novartis Pharmaceuticals | 1 |
| Revolution Medicines, Inc. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Yonsei University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 12 |
| Uterine Cervical Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Cholangiocarcinoma | 2 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.